Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles
Abstract
We report a novel post-loading approach for constructing a multifunctional biodegradable polyacrylamide (PAA) nanoplatform for tumor-imaging (fluorescence) and photodynamic therapy (PDT). This approach provides an opportunity to post-load the imaging and therapeutic agents at desired concentrations. Among the PAA nanoparticles, a formulation containing the photosensitizer, HPPH [3-(1′-hexyloxyethyl)pyropheophorbide-a], and the cyanine dye in a ratio of 2:1 minimized the undesirable quenching of the HPPH electronic excitation energy because of energy migration within the nanoparticles and/or Förster (fluorescence) resonance energy transfer (FRET) between HPPH and cyanine dye. An excellent tumor-imaging (NIR fluorescence) and phototherapeutic efficacy of the nanoconstruct formulation is demonstrated. Under similar treatment parameters the HPPH in 1% Tween 80/5% aqueous dextrose formulation was less effective than the nanoconstruct containing HPPH and cyanine dye in a ratio of 2 to 1. This is the first example showing the use of the post-loading approach in developing a nanoconstructs for tumor-imaging and therapy.
Graphical Abstract
Long wavelength photosensitizer (PS) and NIR cyanine dye (CD) were post-loaded to PAA NPs in variable ratios. Among all the preparations, the nanoplatform containing the PS and CD in a ratio of two to one (2:1) showed the best tumor-imaging (fluorescence) and PDT efficacy (six of ten mice [BALB/c mice bearing Colon 26 tumors] were tumor free on day 60). Under similar treatment parameters the PS (HPPH) in 1% Tween 80/5% aqueous dextrose formulation was 20% less effective.
Keywords: Near-infrared fluorescence imaging, Photodynamic therapy, Post-loading, Polyacrylamide nanoparticles
To access this article, please choose from the options below
The authors declare no conflicts of interest. A part of the technology presented in this manuscript is licensed to Photolitec, LLC, Buffalo, New York.
Support was received from National Institute of Health grant CA119358 and the shared resources of the Roswell Park Cancer Center support grant CA16056.
PII: S1549-9634(11)00532-6
doi:10.1016/j.nano.2011.11.011
© 2011 Elsevier Inc. All rights reserved.

